JNJ — Recent News Coverage
All news mentioning JNJ in ESEN's AI-graded feed
News stories with JNJ as an affected ticker. Each article is graded by ESEN AI for impact level and direction (up/down/flat) on JNJ. See /coverage/JNJ for the 30-day aggregate.
ZACKS.COM
·
2026-08-14
LOW
NEUTRAL
CORR0.42
Why Is Johnson & Johnson (JNJ) Up 4.8% Since Last Earnings Report?
$JNJ
◈ ESEN AI
Johnson & Johnson (JNJ) has appreciated 4.8% in the 30 days following its most recent earnings release, prompting analysis of what may drive the stock's next moves. The post-earnings rally reflects typical market digest…
INSIDERMONKEY.COM
·
2026-08-10
LOW
NEUTRAL
CORR0.42
Johnson & Johnson vs Abbott Laboratories: Which Healthcare Giant Offers the More Compelling Growth Story After Earnings?
$JNJ
$ABT
◈ ESEN AI
Johnson & Johnson reported Q2 2026 sales of $25.31 billion, a 7% year-over-year increase that marginally exceeded consensus expectations of $25.05 billion. While the beat demonstrates operational execution, the magnitud…
INSIDERMONKEY.COM
·
2026-08-10
NEUTRAL
BULLISH
CORR0.55
Jim Cramer Highlights Pharmaceutical Giants as Non-Tech Innovation Plays Like JNJ and LLY
$JNJ
$LLY
$AMGN
$BMY
◈ ESEN AI
The article reflects a thematic rotation narrative where portfolio managers seek innovation exposure outside the technology sector after an extended tech rally. Large-cap pharmaceutical companies—particularly JNJ, LLY, …
FINANCE.YAHOO.COM
·
2026-08-10
NEUTRAL
NEUTRAL
CORR0.55
Can Johnson & Johnson (JNJ) Challenge Intuitive Surgical (ISRG) After Ottava’s FDA Approval?
$JNJ
$ISRG
◈ ESEN AI
Johnson & Johnson (JNJ) has obtained FDA De Novo authorization for its OTTAVA robotic surgical system, marking formal entry into the soft-tissue robotic surgery market. This regulatory milestone validates J&J's MedTech …
FINANCE.YAHOO.COM
·
2026-08-08
NEUTRAL
BULLISH
CORR0.58
Competition Is Heating Up, but Here's Why Intuitive Surgical Might Still Be the Smartest Bet in MedTech
$ISRG
$MDT
$JNJ
◈ ESEN AI
ISRG maintains competitive positioning in surgical robotics despite intensifying market competition. The article frames the company's installed base and recurring revenue model as structural advantages that create switc…
CNBC.COM
·
2026-08-06
NEUTRAL
BULLISH
CORR0.68
Jim Cramer highlights 5 investing themes — and the stocks to buy for each
$JNJ
◈ ESEN AI
Jim Cramer's thematic analysis post-earnings season reflects a rotation toward identified structural themes rather than broad market commentary. By isolating five investing themes from earnings data, this framework atte…
FINANCE.YAHOO.COM
·
2026-08-05
NEUTRAL
BULLISH
CORR0.52
The companies defying macro uncertainty and raising guidance: AlphaCheck
$JNJ
◈ ESEN AI
This article examines a cohort of companies that are raising earnings guidance despite broad macroeconomic headwinds, signaling management confidence in near-term operational performance. The willingness of firms to inc…
INSURANCEJOURNAL.COM
·
2026-08-04
HIGH
BULLISH
CORR0.72
California Supreme Court Rules for Gilead, Says Drugmakers Don’t Have ‘Duty to Innovate’
$GILD
$JNJ
$PFE
$MRK
◈ ESEN AI
California's Supreme Court decision establishes a significant legal precedent limiting litigation exposure for pharmaceutical manufacturers. The ruling clarifies that companies have no obligation to develop alternative …
SEEKINGALPHA.COM
·
2026-08-03
NEUTRAL
BULLISH
CORR0.52
Johnson & Johnson (JNJ) Discusses FDA Authorization and Market Introduction of OTTAVA Robotic Surgical System Transcript
$JNJ
◈ ESEN AI
Johnson & Johnson (JNJ) has secured FDA authorization for its OTTAVA robotic surgical system and is moving toward market introduction. This represents a meaningful expansion of the company's surgical robotics portfolio,…
FINANCE.YAHOO.COM
·
2026-08-03
NEUTRAL
BULLISH
CORR0.55
Jim Cramer Analyzes Johnson & Johnson (JNJ) After Surgical Robotics Milestone
$JNJ
◈ ESEN AI
Johnson & Johnson (JNJ) received validation from equity commentator Jim Cramer following FDA clearance of its OTTAVA Robotic Surgical System. The approval represents a strategic expansion into the high-margin surgical r…
INSIDERMONKEY.COM
·
2026-08-03
NEUTRAL
BULLISH
CORR0.58
Jim Cramer Analyzes Johnson & Johnson (JNJ) After Surgical Robotics Milestone
$JNJ
$ISRG
$SYK
$MDT
◈ ESEN AI
Johnson & Johnson (JNJ) received positive commentary from analyst Jim Cramer following what the market perceives as a meaningful advancement in surgical robotics capabilities. This sentiment shift reflects growing insti…
PROFITCONFIDENTIAL.COM
·
2026-08-03
HIGH
BEARISH
CORR0.42
Johnson & Johnson to Pay $5.5 Billion in Landmark Settlement Over Talc Lawsuits
$JNJ
◈ ESEN AI
Johnson & Johnson has agreed to a $5.5 billion settlement to resolve talc-related litigation, marking a material financial liability that reduces shareholder equity and free cash flow availability. This landmark agreeme…
ZACKS.COM
·
2026-08-03
NEUTRAL
NEUTRAL
CORR0.42
Is It Worth Investing in Johnson & Johnson (JNJ) Based on Wall Street's Bullish Views?
$JNJ
◈ ESEN AI
Johnson & Johnson (JNJ) maintains an average brokerage recommendation equivalent to Buy, reflecting institutional consensus on the stock's fundamental positioning. However, this article raises a critical methodological …
FINANCE.YAHOO.COM
·
2026-08-02
LOW
BULLISH
CORR0.42
3 Dividend Stocks That Are No-Brainer Buys for the Second Half of 2026
$JNJ
◈ ESEN AI
This article presents a defensive positioning recommendation centered on dividend-paying blue-chip stocks as a tactical response to recent equity pullbacks. The framing suggests market volatility is creating valuation o…
FINANCE.YAHOO.COM
·
2026-08-01
NEUTRAL
NEUTRAL
CORR0.42
XLV vs PBE: Is a Low-Cost Healthcare ETF the Better Buy Than a Focused Biotech Specialist?
$XLV
$PBE
$AMGN
$JNJ
◈ ESEN AI
The comparison between XLV and PBE reflects a classic trade-off in healthcare investing: concentrated volatility versus diversified stability. PBE's 41% annual surge demonstrates the upside potential of biotech-focused …
FINANCE.YAHOO.COM
·
2026-08-01
NEUTRAL
BULLISH
CORR0.72
Healthcare Stocks Are Having a Good Year. Should You Buy a Fidelity or iShares ETF to Profit?
$FHLC
$IYH
$JNJ
$ABBV
◈ ESEN AI
Healthcare equities have demonstrated notable outperformance year-to-date, prompting investor interest in sector-specific exchange-traded funds as a capital allocation vehicle. The article compares two distinct approach…
CNBC.COM
·
2026-07-30
NEUTRAL
NEUTRAL
CORR0.42
AI stocks rebound, and why J&J's earnings guidance cut is not cause for concern
$NVDA
$AMD
$AAPL
$JNJ
◈ ESEN AI
The market is absorbing mixed fundamental signals across two distinct narratives: AI equities are recovering from recent weakness, suggesting renewed institutional conviction in semiconductor and software valuations des…
ECONOMICTIMES.INDIATIMES.COM
·
2026-07-30
HIGH
BULLISH
CORR0.72
Johnson & Johnson seeks to end decade-long talc litigation with $5.5 billion settlement
$JNJ
◈ ESEN AI
Johnson & Johnson has reached a comprehensive settlement framework worth $5.5 billion to resolve a decade-long talc litigation saga. This agreement represents a definitive resolution path after prior bankruptcy restruct…
BUSINESSWIRE
·
2026-07-29
NEUTRAL
BULLISH
CORR0.58
Johnson & Johnson Completes Acquisition of Firefly Bio, Inc. to Advance Next-Generation Oncology Innovation
$JNJ
◈ ESEN AI
Johnson & Johnson has completed its $1 billion acquisition of Firefly Bio, a biotechnology firm specializing in degrader antibody conjugate (DAC) technology. This transaction represents a strategic bolt-on that expands …
CNBC.COM
·
2026-07-29
NEUTRAL
BEARISH
CORR0.15
Here's a closer look at our decision to change course on P&G
$PG
$JNJ
◈ ESEN AI
A portfolio manager has disclosed a decision to exit or reduce exposure to Procter & Gamble (PG), citing deteriorating fundamental thesis and minimal remaining capital allocation. The commentary suggests the thesis unde…
FINANCE.YAHOO.COM
·
2026-07-29
HIGH
BULLISH
CORR0.72
Explainer-Can J&J finally put the talc litigation behind it?
$JNJ
◈ ESEN AI
Johnson & Johnson (JNJ) announced a settlement of at least $5.5 billion to resolve decades-old talc litigation, marking a potential turning point for a company burdened by over a decade of legal uncertainty. This repres…
FORBES.COM
·
2026-07-29
NEUTRAL
NEUTRAL
CORR0.15
The Startup Using AI To Make Hearing Aids Better
$JNJ
◈ ESEN AI
This article aggregates multiple healthcare and medtech innovation stories, with J&J's $5.5 billion talc settlement representing the most material corporate event. The settlement reflects historical litigation costs rat…
FINANCE.YAHOO.COM
·
2026-07-29
NEUTRAL
NEUTRAL
CORR0.42
Johnson & Johnson vs. Eli Lilly: Reliable Stability vs. Rapid Revenue Growth
$JNJ
$LLY
◈ ESEN AI
Johnson & Johnson and Eli Lilly present a study in contrasting growth trajectories within pharmaceutical and life sciences. While JNJ has maintained steady, predictable revenue expansion reflective of a mature diversifi…
CNBC.COM
·
2026-07-28
NEUTRAL
NEUTRAL
CORR0.15
Jim Cramer says Wall Street is fleeing the AI trade and buying these stocks instead
$JNJ
$NVDA
$AMD
◈ ESEN AI
Market participants are executing a tactical rotation out of memory-chip and AI-infrastructure beneficiaries toward diversified growth names with revenue streams independent of data-center capex cycles. This signals nei…
CNBC
·
2026-07-28
NEUTRAL
BULLISH
CORR0.42
Jim Cramer: J&J talc settlement is good for a stock that has so much going for it already
$JNJ
◈ ESEN AI
Johnson & Johnson's talc settlement resolution removes a significant legacy overhang that has weighed on investor sentiment for years. Cramer's characterization of current market dynamics as a "J&J market" suggests the …
FASTCOMPANY.COM
·
2026-07-28
HIGH
BEARISH
CORR0.42
Johnson & Johnson offers $5.5 billion to settle remaining lawsuits over talc products linked to cancer
$JNJ
◈ ESEN AI
Johnson & Johnson is committing an additional $5.5 billion to resolve the tail end of talc-related litigation, representing a material corporate obligation that extends legal uncertainty well into future periods. This s…
FOXBUSINESS.COM
·
2026-07-28
HIGH
BEARISH
CORR0.42
Johnson & Johnson agrees to pay $5.5B to settle talc lawsuits
$JNJ
◈ ESEN AI
Johnson & Johnson announced a $5.5 billion settlement to resolve approximately 61,000 talc-related lawsuits alleging its baby powder caused ovarian cancer. This represents a material cash outlay that will flow from oper…
FINANCE.YAHOO.COM
·
2026-07-28
NEUTRAL
NEUTRAL
CORR0.15
Analysis-Trump's diversity crackdown reverberates through US boardrooms
$JNJ
◈ ESEN AI
The article examines policy-driven pressure on corporate diversity, equity, and inclusion (DEI) initiatives across U.S. boardrooms. This represents a structural shift in governance priorities rather than a traditional f…
ABCNEWS.GO.COM
·
2026-07-28
HIGH
BEARISH
CORR-0.28
Johnson & Johnson proposes $5.5 billion talc settlement to end marathon legal fight
$JNJ
◈ ESEN AI
Johnson & Johnson announced a $5.5 billion settlement to resolve outstanding talc litigation, representing a material capital allocation that reduces financial flexibility and signals closure on a long-running legal lia…
LIVEMINT.COM
·
2026-07-28
HIGH
BEARISH
CORR-0.72
Johnson & Johnson to pay nearly ₹52,700 crore after lawsuits linked baby powder to ovarian cancer
$JNJ
◈ ESEN AI
Johnson & Johnson (JNJ) faces a significant financial settlement of approximately ₹52,700 crore (roughly $6.3 billion USD equivalent) stemming from accumulated talc-related litigation. This represents a material liabili…
MANILATIMES.NET
·
2026-07-28
HIGH
BEARISH
CORR0.42
Johnson & Johnson offers $5.5B to settle talc lawsuits
$JNJ
◈ ESEN AI
Johnson & Johnson announced a $5.5 billion settlement offer to resolve thousands of talc-related litigation claims alleging causation between talcum powder products and ovarian cancer. This represents a material capital…
TIMWORSTALL.COM
·
2026-07-28
HIGH
BEARISH
CORR0.42
Not that I know anything here
$JNJ
◈ ESEN AI
Johnson & Johnson (JNJ) has agreed to a $5.5 billion settlement to resolve approximately tens of thousands of lawsuits alleging its talc-based baby powder and related products caused ovarian cancer. This landmark agreem…
ECONOMICTIMES.INDIATIMES.COM
·
2026-07-28
HIGH
BULLISH
CORR0.72
Johnson & Johnson reaches $5.5 bn talc settlement that could end decade of litigation
$JNJ
◈ ESEN AI
Johnson & Johnson's $5.5 billion talc settlement represents a major de-risking event that eliminates a decade of litigation overhang. The agreement covers approximately 76,000 claims alleging talc-based cancer causation…
BBC.CO.UK
·
2026-07-28
HIGH
BEARISH
CORR-0.15
Johnson & Johnson offers to pay $5.5bn to settle baby powder lawsuits
$JNJ
◈ ESEN AI
Johnson & Johnson announced a $5.5 billion settlement proposal to resolve multi-year litigation alleging talc-based products caused cancer in consumers. This represents a material cash outflow and formal acknowledgment …
SEEKINGALPHA.COM
·
2026-07-28
HIGH
BEARISH
CORR0.32
Johnson & Johnson to pay up to $5.5B to settle talc lawsuits (JNJ:NYSE)
$JNJ
◈ ESEN AI
Johnson & Johnson has committed to a $5.5 billion settlement to resolve ongoing talc-related litigation alleging links between its talc products and ovarian cancer. This represents a material capital allocation event fo…
INSIDERMONKEY.COM
·
2026-07-27
HIGH
BULLISH
CORR0.72
Johnson & Johnson (JNJ) Raised Its Outlook. Is It the Better Healthcare Stock to Own After Earnings?
$JNJ
◈ ESEN AI
Johnson & Johnson posted Q2 2026 results that exceeded consensus expectations, with quarterly sales reaching $25.31 billion versus the $25.05 billion analyst estimate. This 7% year-over-year growth signals sustained mom…
CNBC.COM
·
2026-07-27
NEUTRAL
NEUTRAL
CORR0.15
More tech pain means gains elsewhere. What's winning in Monday's mixed market
$JNJ
◈ ESEN AI
Market dynamics show a classic sector rotation pattern as technology weakness creates opportunity in defensive and cyclical alternatives. The headline suggests tech weakness—typically a high-beta, growth-sensitive secto…
INSIDERMONKEY.COM
·
2026-07-27
NEUTRAL
NEUTRAL
CORR0.32
President Trump Loves Johnson & Johnson (JNJ), But Insiders Are Selling
$JNJ
◈ ESEN AI
The article highlights that Johnson & Johnson (JNJ) appears in President Trump's recent financial disclosures, suggesting institutional proximity and political alignment with the executive branch. This proximity could t…
FINANCE.YAHOO.COM
·
2026-07-27
NEUTRAL
NEUTRAL
CORR0.15
President Trump Loves Johnson & Johnson (JNJ), But Insiders Are Selling
$JNJ
◈ ESEN AI
Johnson & Johnson (JNJ) has attracted presidential interest as disclosed in recent financial filings, positioning the health care giant within the broader political narrative around pharmaceutical and medical device lea…
ZACKS.COM
·
2026-07-27
NEUTRAL
BULLISH
CORR0.72
Zacks Investment Ideas feature highlights: General Motors, Abbott Laboratories and Johnson & Johnson
$GM
$ABT
$JNJ
◈ ESEN AI
GM, ABT, and JNJ have demonstrated earnings resilience during the current reporting cycle, each raising forward guidance and delivering results that exceeded consensus expectations. This pattern suggests management conf…
SEEKINGALPHA.COM
·
2026-07-26
HIGH
NEUTRAL
CORR0.72
Wall Street Week Ahead
$JNJ
◈ ESEN AI
This week presents three macro-level catalysts with potential to move broad equity markets: a Federal Reserve rate decision, core PCE inflation data release, and a concentrated batch of Big Tech earnings reports. The co…
FINANCE.YAHOO.COM
·
2026-07-25
LOW
NEUTRAL
CORR0.15
Claiming Social Security at 62 vs. Building a Dividend Bridge: Which Leaves You Richer at 75?
$JNJ
◈ ESEN AI
This article examines a personal financial optimization problem: the trade-off between claiming Social Security early at 62 versus delaying until 70, with dividend-generating securities serving as a bridge income source…
CNBC.COM
·
2026-07-25
HIGH
BEARISH
CORR0.72
Here are 4 forces that drove a tough week for stocks
$AAPL
$GOOGL
$MSFT
$JNJ
$ISRG
◈ ESEN AI
A confluence of macro headwinds and sector-specific catalysts pressured equity markets during the week, with technology leaders AAPL, GOOGL, and MSFT showing particular vulnerability. The combination of geopolitical ris…
SEEKINGALPHA.COM
·
2026-07-25
LOW
NEUTRAL
CORR0.15
Insider trades: Johnson & Johnson, TSMC among notable names (AA:NYSE)
$JNJ
$MMM
$SNAP
$UAL
$AA
◈ ESEN AI
This insider trading roundup aggregates disclosed transactions across JNJ, MMM, SNAP, UAL, AA, and TSM, spanning healthcare, industrials, communications, and semiconductors. Insider activity data serves as a supplementa…
INSIDERMONKEY.COM
·
2026-07-25
LOW
NEUTRAL
CORR0.42
Jim Cramer Said To Buy Johnson & Johnson (NYSE:JNJ)’s Shares – Here’s What Happened Next
$JNJ
◈ ESEN AI
Johnson & Johnson (JNJ) remains positioned as a core healthcare holding despite recent share underperformance, according to commentary attributed to prominent market analyst Jim Cramer. This designation reflects confide…
SEEKINGALPHA.COM
·
2026-07-22
HIGH
BEARISH
CORR0.42
Intuitive Surgical down as J&J wins FDA nod for surgical robot
$JNJ
$ISRG
$MDT
◈ ESEN AI
JNJ's FDA clearance of the Ottava surgical robot represents a significant competitive inflection point in the minimally invasive surgery market. This regulatory milestone shifts the competitive landscape by introducing …
SEEKINGALPHA.COM
·
2026-07-22
NEUTRAL
NEUTRAL
CORR0.42
Genmab: Multiple Late-Stage Readouts Ahead (NASDAQ:GMAB)
$GMAB
$JNJ
◈ ESEN AI
Genmab (GMAB) faces a valuation disconnect between operational momentum and equity performance year-to-date. The biotech firm's commercial execution and pipeline advancement have demonstrated tangible progress, yet the …
SEEKINGALPHA.COM
·
2026-07-22
NEUTRAL
BULLISH
CORR0.58
J&J wins FDA nod for Ottava surgical robot (JNJ:NYSE)
$JNJ
◈ ESEN AI
Johnson & Johnson (JNJ) secured FDA De Novo authorization for its Ottava soft tissue robotic surgical system, a regulatory milestone that validates the company's advanced surgical robotics platform. De Novo clearance re…
ECONOMICTIMES.INDIATIMES.COM
·
2026-07-22
HIGH
BULLISH
CORR0.72
Johnson & Johnson's robotic surgery device gets US FDA marketing authorization
$JNJ
◈ ESEN AI
Johnson & Johnson has achieved a significant regulatory milestone with FDA marketing authorization for its Ottava robotic surgical system, marking formal entry into the high-growth soft-tissue robotic surgery segment. T…
THEHINDUBUSINESSLINE.COM
·
2026-07-22
NEUTRAL
BEARISH
CORR-0.72
Markets in pressure at midday; banking, IT, pharma drag; auto bucks trend
$SBKFF
$JPM
$XLK
$JNJ
◈ ESEN AI
Midday trading revealed broad equity weakness across India's benchmark indices, with Sensex and Nifty experiencing sharp declines amid intensified institutional selling. The selloff concentrated in three systemically im…
EXPLORE OTHER FILTERS